Ticagrelor and Fazamorexant Drug Interaction Alters Pharmacokinetics in Healthy Volunteers
Viral Science News A new phase I clinical study has mapped how two widely discussed drugs—ticagrelor and fazamorexant—may interact in...
Iris Marlowe reports on pharmacology and drug discovery, tracking therapeutic targets, preclinical findings, clinical candidates, safety signals, and new treatment strategies.
Viral Science News A new phase I clinical study has mapped how two widely discussed drugs—ticagrelor and fazamorexant—may interact in...
Insilico Medicine founders Dr. Alex Zhavoronkov and Dr. Feng Ren have been invited to the inaugural China Pioneer Innovative Drug...
TUCSON, Ariz., July 16, 2026 — Critical Path Institute’s® (C-Path) New Approach Methodologies Developer Coalition (NAMs-DC) has added Crown Bioscience...
Glioblastoma remains one of the deadliest brain cancers, notorious for its resistance to standard therapy and its ability to adapt...
Insilico Medicine, a clinical-stage generative AI drug discovery company, has announced a multi-target strategic alliance with Bora Pharmaceuticals, a global...
In a groundbreaking advancement for targeted drug delivery, an international team of scientists has successfully combined asymmetric-flow field-flow fractionation (AF4)...
A groundbreaking meta-analysis has emerged, shedding unprecedented light on the pharmacological strategies employed to combat muscular degeneration in Duchenne muscular...
In the relentless pursuit of new therapeutics, structure-based virtual screening (VS) through molecular docking has cemented its role as a...
In a groundbreaking advancement for pharmaceutical innovation, Insilico Medicine and SK Biopharmaceuticals have announced an ambitious AI-powered collaboration targeting neuroimmune...
The International Society for Stem Cell Research (ISSCR) has announced a pivotal advancement in the realm of biomedical research with...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine